4,710
Views
22
CrossRef citations to date
0
Altmetric
REVIEW: MEDICAL ONCOLOGY

PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis

, , &
Pages 66-74 | Received 12 May 2019, Accepted 02 Sep 2019, Published online: 23 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Juanzi Zeng, Wenwei Fan, Jiaquan Li, Guowu Wu & Heming Wu. (2023) KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer. International Journal of General Medicine 16, pages 4109-4120.
Read now

Articles from other publishers (21)

Devesh u kapoor, Rahul Garg, Mansi Gaur, Bhupendra G. Prajapati, Gyan Agrawal, Sankha Bhattacharya & Gehan M. Elossaily. (2023) Polymeric nanoparticles approach and identification and characterization of novel biomarkers for colon cancer. Results in Chemistry 6, pages 101167.
Crossref
Antonino Glaviano, Aaron S. C. Foo, Hiu Y. Lam, Kenneth C. H. Yap, William Jacot, Robert H. Jones, Huiyan Eng, Madhumathy G. Nair, Pooyan Makvandi, Birgit Geoerger, Matthew H. Kulke, Richard D. Baird, Jyothi S. Prabhu, Daniela Carbone, Camilla Pecoraro, Daniel B. L. Teh, Gautam Sethi, Vincenzo Cavalieri, Kevin H. Lin, Nathalie R. Javidi-Sharifi, Eneda Toska, Matthew S. Davids, Jennifer R. Brown, Patrizia Diana, Justin Stebbing, David A. Fruman & Alan P. Kumar. (2023) PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Molecular Cancer 22:1.
Crossref
Joao Manzi, Camilla O. Hoff, Raphaella Ferreira, Agustin Pimentel, Jashodeep Datta, Alan S. Livingstone, Rodrigo Vianna & Phillipe Abreu. (2023) Targeted Therapies in Colorectal Cancer: Recent Advances in Biomarkers, Landmark Trials, and Future Perspectives. Cancers 15:11, pages 3023.
Crossref
Ingrid M. Montes‐Rodríguez, Hilmaris Centeno‐Girona, Camila Rivera‐Lynch, Noridza Rivera & Marcia Cruz‐Correa. (2023) Molecular profiling of colorectal cancer in a genetically admixed Hispanic population. Cancer Medicine 12:10, pages 11686-11702.
Crossref
Alexandra Kavun, Egor Veselovsky, Alexandra Lebedeva, Ekaterina Belova, Olesya Kuznetsova, Valentina Yakushina, Tatiana Grigoreva, Vladislav Mileyko, Mikhail Fedyanin & Maxim Ivanov. (2023) Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy. Cancers 15:8, pages 2288.
Crossref
·如孜 卡地力艳. (2023) Molecular Mechanism and Clinical Application of Thyroid Cancer. Advances in Clinical Medicine 13:12, pages 20543-20548.
Crossref
Marcelo Vital, Florencia Carusso, Carolina Vergara, Florencia Neffa, Adriana Della Valle & Patricia Esperón. (2023) Genetic and epigenetic characteristics of patients with colorectal cancer from Uruguay. Pathology - Research and Practice 241, pages 154264.
Crossref
Ashleigh C. Hamilton, Finian J. Bannon, Philip D. Dunne, Jacqueline James, Stephen McQuaid, Ronan T. Gray, Manuel Salto-Tellez, Chris R. Cardwell, Maurice B. Loughrey & Helen G. Coleman. (2023) Distinct Molecular Profiles of Sporadic Early-Onset Colorectal Cancer: A Population-Based Cohort and Systematic Review. Gastro Hep Advances 2:3, pages 347-359.
Crossref
Lu Yang, Arup Bhattacharya, Yun Li, Sandra Sexton, Xiang Ling, Fengzhi Li & Yuesheng Zhang. (2022) Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Igor P. Oscorbin, Oguljan P. Beginyazova, Inna V. Khlistun, Darya V. Shamovskaya, Natalia A. Oskina & Maxim L. Filipenko. (2022) Development of a multiplex allele-specific qPCR approach for testing PIK3CA mutations in patients with colorectal cancer. Heliyon 8:11, pages e11804.
Crossref
Kai Li & Weixing Wang. (2022) Establishment of m7G-related gene pair signature to predict overall survival in colorectal cancer. Frontiers in Genetics 13.
Crossref
Melanie Demes, Ursula Pession, Jan Jeroch, Falko Schulze, Katrin Eichler, Daniel Martin, Peter Wild & Oliver Waidmann. (2022) Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and MLH1 mutation . Oncotarget 13:1, pages 1034-1042.
Crossref
Omshree Shetty, Vaibhavi Vengurlekar, Akhil Kapoor, Vishakha Kamble, Mamta Gurav, Prabhat Bhargava, Sujay Srinivas, Anant Ramaswamy, Mukta Ramadwar, Avanish P. Saklani, Ashwin Desouza & Vikas Ostwal. (2022) The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal Cancer. South Asian Journal of Cancer 11:03, pages 190-194.
Crossref
Vania Myralda Giamour Marbun, Linda Erlina & Toar Jean Maurice Lalisang. (2022) Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer. PLOS ONE 17:6, pages e0267090.
Crossref
Maryam Alizadeh-Sedigh, Habibollah Mahmoodzadeh, Mohammad Sadegh Fazeli, Mohammad Haddadi-Aghdam & Ladan Teimoori-Toolabi. (2022) The potential of PIK3CA, KRAS, BRAF, and APC hotspot mutations as a non-invasive detection method for colorectal cancer. Molecular and Cellular Probes 63, pages 101807.
Crossref
Yongle Chen, Zexian Chen, Juanni Huang, Jiancong Hu, Xiaowen He, Ping Lan & Xiaosheng He. (2022) Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location. International Journal of Clinical Oncology 27:4, pages 749-755.
Crossref
Hanlin Jiang, Hui Xi, Mario Juhas & Yang Zhang. (2021) Biosensors for Point Mutation Detection. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Hong Yuan, Jun Ji, Min Shi, Yan Shi, Jing Liu, Junwei Wu, Chen Yang, Wenqi Xi, Qingyuan Li, Wei Zhu, Jingjie Li, Xiaoli Gong & Jun Zhang. (2021) Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden. Frontiers in Oncology 11.
Crossref
Ichiro Abe & Alfred King-yin Lam. (2021) Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics. Current Oncology Reports 23:3.
Crossref
Reetu Mukherji, John Marshall & Andreas Seeber. (2020) Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives. Cancers 12:8, pages 2001.
Crossref
Ningni Jiang, Qijie Dai, Xiaorui Su, Jianjiang Fu, Xuancheng Feng & Juan Peng. (2020) Role of PI3K/AKT pathway in cancer: the framework of malignant behavior. Molecular Biology Reports 47:6, pages 4587-4629.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.